Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 125151
Company: SHIRE
Company: SHIRE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ELAPRASE | IDURSULFASE | 6MG/3ML | INJECTABLE; IV (INFUSION) | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
07/24/2006 | ORIG-1 | Approval | N/A; Orphan |
Letter (PDF)
Review |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/125151s0000_Ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/125151s0000_ElapraseTOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
11/16/2018 | SUPPL-197 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125151s197lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125151Orig1s197ltr.pdf | |
06/24/2013 | SUPPL-184 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125151s0184lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/125151Orig1s152,s184ltr.pdf | |
06/24/2013 | SUPPL-152 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125151s0152lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/125151Orig1s152,s184ltr.pdf | |
03/08/2011 | SUPPL-151 | Supplement |
Label is not available on this site. |
||
11/29/2010 | SUPPL-140 | Supplement |
Label is not available on this site. |
||
10/24/2007 | SUPPL-32 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/125151s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/125151s032ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
11/16/2018 | SUPPL-197 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125151s197lbl.pdf | |
11/16/2018 | SUPPL-197 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125151s197lbl.pdf | |
06/24/2013 | SUPPL-184 | Efficacy | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125151s0184lbl.pdf | |
06/24/2013 | SUPPL-152 | Efficacy | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125151s0152lbl.pdf | |
10/24/2007 | SUPPL-32 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/125151s032lbl.pdf |